Cleared Traditional

K132583 - EZ-IO INTRAOSSEOUS INFUSION SYSTEM

K132583 is an FDA 510(k) clearance for EZ-IO INTRAOSSEOUS INFUSION SYSTEM, manufactured by Vidacare Corporation. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 179-day FDA review.

K132583 · Vidacare Corporation · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2014
Decision
179d
Days
Class 2
Risk

K132583 is an FDA 510(k) clearance for the EZ-IO INTRAOSSEOUS INFUSION SYSTEM. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Vidacare Corporation (Shavano Park, US). The FDA issued a Cleared decision on February 11, 2014 after a review of 179 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Vidacare Corporation devices

FDA 510(k) Submission Details - K132583

510(k) Number K132583 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 16, 2013
Decision Date February 11, 2014
Days to Decision 179 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d slower than avg
Panel avg: 129d · This submission: 179d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 500
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K132583.
CAREFINE PEN NEEDLE WITH QUINTAPOINT AND SUPERPOINT
K140568 · Facet Technologies, LLC · May 2014
INSULIN PEN NEEDLE
K133058 · Wenzhou Wuzhou Import & Export Co., Ltd. · Feb 2014
INSULIN PEN NEEDLE
K133059 · Wenzhou Beipu Science & Technology Co., Ltd. · Feb 2014
CAREFINE PEN NEEDLE
K133100 · Facet Technologies · Jan 2014
SAFETY HYPODERMIC NEEDLES WITH/WITHOUT SYRINGE
K130212 · Wuxi Yushou Medical Applicances Co., Ltd. · Nov 2013
U&U STERILE HYPODERMIC NEEDLE
K132552 · U&U Medical Technology Co, Ltd. · Nov 2013